Address
Email address
https://genecode.comGenecode - Reversing Neurodegeneration - Restoring Life.Defeating neurodegenerative diseases by developing systemically, available, safe and effective medicines, building on a deep understanding of neurodegeneration and regeneration of the nervous system.
Name
Uno VC OÜ
Registry code
16030635
VAT number
EE102287488
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
17.08.2020 (5)
Financial year
01.01-31.12
Capital
50 000.00 €
Activity
68201 - Rental and operating of own or leased real estate
8 000 €
-36 033 €
-450%
-
925 599 €
0
Submitted
No tax arrears
-4%
-3%
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Paavo Pilv
| 100% - 50 000.00 EUR | Board member | Direct ownership |
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| MPPS Investeeringud OÜ 10634869 | 35% - 8 946.00 EUR | - | - |
| Multilink OÜ 11040758 | 25% - 704.00 EUR | - | - |
| 2021 25.11.2022 | 2022 06.06.2023 | 2023 06.04.2024 | 2024 28.06.2025 | |
|---|---|---|---|---|
| Total Revenue | 0 € | 0 € | 8 382 € | 8 000 € |
| Net profit (loss) for the period | -240 € | 481 089 € | 83 995 € | -36 033 € |
| Profit Margin | - | - | 1002% | -450% |
| Current Assets | 26 371 € | 25 620 € | 78 934 € | 51 546 € |
| Fixed Assets | - | 616 777 € | 1 060 611 € | 1 032 410 € |
| Total Assets | 26 371 € | 642 397 € | 1 139 545 € | 1 083 956 € |
| Current Liabilities | - | 1 060 € | 8 988 € | 7 527 € |
| Non Current Liabilities | - | 11 171 € | 168 925 € | 150 830 € |
| Total Liabilities | - | 12 231 € | 177 913 € | 158 357 € |
| Share Capital | 40 000 € | - | - | - |
| Equity | 26 371 € | 630 166 € | 961 632 € | 925 599 € |
| Employees | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2025 Q4 | 0 € | 0 € | 0 € | - |
| 2025 Q3 | 0 € | 0 € | 0 € | - |
| 2025 Q2 | 0 € | 0 € | 0 € | - |
| 2025 Q1 | 0 € | 0 € | 0 € | - |
| 2024 Q4 | 1 326 € | 0 € | 0 € | - |
| 2024 Q3 | 3 334 € | 0 € | 0 € | - |
| 2024 Q2 | 0 € | 0 € | 0 € | - |
| 2024 Q1 | 0 € | 0 € | 0 € | - |
| 2023 Q4 | 0 € | 0 € | 0 € | - |
| 2023 Q3 | 0 € | 0 € | 0 € | - |
| 2023 Q2 | 0 € | 0 € | 0 € | - |
| 2023 Q1 | 0 € | 0 € | 0 € | - |
| 2022 Q4 | 0 € | 0 € | 0 € | - |
| 2022 Q3 | 0 € | - | - | - |
| 2022 Q2 | 0 € | - | - | - |
| 2022 Q1 | 0 € | - | - | - |
